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Exercise training benefits many organ systems and
offers protection against metabolic disorders such
as obesity and diabetes. Using the recently identified
isoform of PGC1-a (PGC1-a4) as a discovery tool, we
report the identification of meteorin-like (Metrnl), a
circulating factor that is induced in muscle after
exercise and in adipose tissue upon cold exposure.
Increasing circulating levels of Metrnl stimulates
energy expenditure and improves glucose tolerance
and the expression of genes associated with beige
fat thermogenesis and anti-inflammatory cytokines.
Metrnl stimulates an eosinophil-dependent increase
in IL-4 expression and promotes alternative acti-
vation of adipose tissue macrophages, which are
required for the increased expression of the thermo-
genic and anti-inflammatory gene programs in fat.
Importantly, blocking Metrnl actions in vivo signifi-
cantly attenuates chronic cold-exposure-induced
alternative macrophage activation and thermogenic
gene responses. Thus, Metrnl links host-adaptive
responses to the regulation of energy homeostasis
and tissue inflammation and has therapeutic poten-
tial for metabolic and inflammatory diseases.INTRODUCTION
The incidence of obesity has reached epidemic proportions
worldwide, leading to a concomitant increase in associated dis-
orders such as type II diabetes, cardiovascular disease, and
cancer. As a consequence, there is now great interest in brown
fat, a tissue specialized for the dissipation of chemical energy in
the form of heat. Brown fat defends mammals against hypother-mia, obesity, and type II diabetes. The dissipation of energy by
brown fat cells is dependent on their high mitochondrial content
and the mitochondrial protein UCP-1. This protein catalyzes a
proton leak across the inner mitochondrial membrane, thereby
uncoupling respiration from ATP synthesis. Recent studies
have demonstrated that there are two distinct types of brown
adipocytes. The classical brown fat, as exemplified by the inter-
scapular depot of rodents and infant humans, contains cells
from a muscle-like myf5+, pax7+ cell lineage (Seale et al.,
2008). Many white adipose tissues (WATs) also contain a subset
of cells that can express high levels of UCP-1 upon chronic
exposure to cold and b-adrenergic stimulation (Cousin et al.,
1992; Xue et al., 2005). These cells, called beige or brite fat
cells, do not come from a myf5+ lineage (Seale et al., 2008)
but are capable of elevated fuel oxidation and thermogenesis
(Wu et al., 2012). Recent data demonstrate that ablation of
beige adipose cells selectively makes mice more prone to
obesity and metabolic dysfunction, particularly hepatic insulin
resistance (Cohen et al., 2014). The molecular determinants of
both types of adipocytes have been studied in detail, and key
transcriptional regulators include the key cell fat regulator
PRDM16 (Seale et al., 2008), as well as PGC-1a (Puigserver
et al., 1998), C/EBPb (Karamanlidis et al., 2007), and FOXC2
(Cederberg et al., 2001).
Exercise training is a robust means to increase energy expen-
diture and is also an excellent primary intervention to combat
obesity and associated metabolic disorders (Hawley, 2004;
Pacy et al., 1986). Exercise mediates an increase in the circu-
lating levels of certain hormones released from muscle (myo-
kines), which are known to mediate some of the beneficial
effects of exercise. In addition to increasing energy expenditure,
exercise training also reduces adipose tissue inflammation
(Baynard et al., 2012) (Gleeson et al., 2011), which may be a
mechanism by which exercise training reduces insulin resis-
tance and improves glucose homeostasis. Interestingly, certain
forms of chronic exercise have been found to elevate thermo-
genic activity of beige/brown fat in rodents (Bostro¨m et al.,Cell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc. 1279
2012; Xu et al., 2011), perhaps providing an additional pathway
for some of the chronic benefits of exercise training on glucose
and lipid metabolism.
Many of the best known benefits of endurance training, such
as fiber type switching,mitochondrial biogenesis, and resistance
to muscle atrophy, can be stimulated by expression of the tran-
scriptional coactivator PGC1a in the skeletal muscle (Lin et al.,
2002). PGC1a (now termed PGC1a1) itself is induced by endur-
ance exercise in mice and humans (Akimoto et al., 2005; Mathai
et al., 2008). We recently identified a PGC1a1-dependent mem-
brane protein, Fndc5, which is proteolytically cleaved into a
secreted polypeptide termed irisin, which preferentially induces
UCP-1-positive cells or ‘‘browning’’ of theWAT in cell culture and
in vivo (Bostro¨m et al., 2012; Wu et al., 2012; Zhang et al., 2013).
It also induces a neuroprotective gene program in the hippo-
campi of treated animals (Wrann et al., 2013).
A splice isoform of the PGC-1a gene has been recently iden-
tified that is induced upon resistance exercise and promotes
muscle hypertrophy and strength (Ruas et al., 2012). The en-
coded protein, termed PGC-1a4, does not regulate the mito-
chondrial and oxidative metabolism programs induced by
PGC-1a1, but rather alters expression of a distinct gene set,
including IGF1 and myostatin. These are well-known regulators
of skeletal muscle hypertrophy and strength. Muscle-specific
transgenics expressing PGC-1a4 display increased muscle
size and strength and are resistant to the muscle wasting of can-
cer cachexia. Muscle-specific expression of PGC-1a4 also pro-
duces significant increases in whole-body energy expenditure
(Ruas et al., 2012); however, the underlying mechanisms have
not been explored.
Here, we report that expression of PGC-1a4 in skeletal muscle
stimulates increased mRNA and secretion of a hormone called
meteorin-like (Metrnl). Metrnl is induced after exercise and cold
exposure in the skeletal muscle and adipose tissue, respectively,
and is present in the circulation. Increases in circulating Metrnl
cause an increase in whole-body energy expenditure associated
with the browning of the white fat depots and improve glucose
tolerance in obese/diabetic mice. Interestingly, Metrnl does not
appear to promote an increase in a thermogenic gene program
through a direct action on adipocytes; rather, it stimulates
several immune cell subtypes to enter the adipose tissue and
activate their prothermogenic actions. Finally, Metrnl is required
for a significant portion of cold-induced thermogenic responses,
thereby implicating a key physiological role for Metrnl in meta-
bolic adaptations to cold temperatures.
RESULTS
Muscle-Specific Transgenic Mice Expressing PGC-1a4
Are Lean and Display Browning of White Adipose
Tissues
We recently reported that the muscle-specific PGC-1a4 trans-
genic mice (Myo-PGC-1a4) demonstrate muscle hypertrophy
and increased basal energy expenditure without any changes
in food intake or movement (Ruas et al., 2012). The molecular
basis for the increased energy expenditure was not explored.
As shown in Figure 1A, the Myo-PGC-1a4 mice have an obvious
reduction in the size of epididymal (epi) fat depot and demon-1280 Cell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc.strate30%–40% reduction in the weights of the epi and subcu-
taneous adipose tissue (inguinal) (SubQ WAT), compared to
those of controls (Figure 1B). In addition, the Myo-PGC-1a4
mice demonstrated an overall lean phenotype, as evidenced
by a 43% reduction in whole-body fat content when assessed
by MRI (Figure 1C). Interestingly, the Myo-PGC-1a4 mice gain
significantly less weight after 12 weeks on a high-fat diet (HFD)
compared to their wild-type (WT) littermate controls. No signifi-
cant weight differences were observed prior to the HFD chal-
lenge at 4 weeks of age (Figure 1D).
Increase in adipose thermogenesis can augment whole-body
energy expenditure, independent of physical activity. We there-
fore analyzed the adipose tissues from Myo-PGC-1a4 mice for
expression of genes related to thermogenesis and/or genes
involved in imparting a brown-fat-like program (browning). As
shown in Figure 1E, quantitative PCR (qPCR) analyses of
messenger RNA (mRNA) revealed a robust increase in thermo-
genic, b-oxidation and mitochondrial gene programs, including
UCP-1,Acsl1,PGC-1a, and ERR-a in the subQWAT. In addition,
we also observed significant increases in expression of these
same genes in the epi WAT (Figure 1F), a tissue that has a
much lower capacity to induce activity of brown or beige fat
thermogenic gene programs. However, no significant changes
in these gene expression events were noted in the interscapular
‘‘classical’’ brown adipose tissue (BAT) (Figure S1A available
online). Notably, PGC-1a4 transgene expression is localized to
the skeletal muscle in the Myo-PGC-1a4 mice and is not ex-
pressed in the adipose tissues (Figure S1B). Taken together,
these results indicate that muscle-specific expression of PGC-
1a4 promotes browning of the WAT (both subQ and epi), which
might contribute to the lean phenotype of the Myo-PGC-1a4
mice. These observations also point toward the existence of a
PGC1a4-dependent myokine that mediates muscle-fat cross-
talk to promote expression of a broad beige thermogenic gene
program.
Identification ofMETRNL as aKey PGC-1a4 Target Gene
in Skeletal Muscle
We utilized two independent and unbiased approaches to iden-
tify secreted factors controlled by PGC1a4 that might contribute
to the browning of white fat: gene expression analyses combined
with bioinformatics algorithms and quantitative mass spectrom-
etry of secreted proteins. First, we screened affymetrix data ob-
tained upon PGC1a4 overexpression in primary myotubes (Ruas
et al., 2012) to identify potential candidates that satisfied all
of the following criteria (1) >2-fold change in mRNA expression,
(2) presence of an N-terminal signal peptide, and (3) absence of a
transmembrane domain. The fold change of short-listed genes
was independently confirmed in the quadriceps muscle from
Myo-PGC-1a4 mice by qPCR (list of the short-listed genes,
Table S1). Second, we performed quantitative protein mass
spectrometric analysis to identify secreted factors that were up-
regulated (>2-fold) in serum-free culture supernatants of primary
myotubes after forced expression of PGC-1a4 (Table S2). The
list of short-listed candidates from both these approaches
were then cross-referenced, and only those gene candidates
that were increased with both of these approaches were
selected (Table S3). Potential candidates were further selected
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Figure 1. Muscle-Specific PGC1a4 Trans-
genic Mice Are Lean and Display Increased
Thermogenesis in the Adipose Tissue
(A) Representative images of epi fat from WT or
Myo-PGC1a4 mice.
(B) Determination of SubQ, Epi, and BAT weights
from WT (n = 5) and Myo-PGC1a4 mice (n = 7).
(C) Determination of percent fat mass betweenWT
and Myo-PGC1a4 mice using MRI (n = 6).
(D) Body weights of WT and Myo-PGC1a4 mice
upon challenging with HFD starting at 4 weeks
(n = 10).
(E and F) Real-time PCR (qPCR) analysis of
markers associated with thermogenic, mitochon-
drial, and b-oxidation genes in (E) subQ and (F) epi
adipose tissue of WT and Myo-PGC1a4 (n = 6).
*p < 0.05, **p < 0.001, and ***p < 0.0001.
All data are presented as mean ± SEM. See also
Figure S1.based on their mRNA abundance in skeletal muscle from WT
mice as quantified by absolute levels of expression by qPCR
(Table S3).
Based on the above criteria, we focused on a protein called
Metrnl. Metrnl mRNA was upregulated about 4-fold in the
mRNA isolated from quadriceps muscle from Myo-PGC-1a4
mice (Figure 2A), and the protein was increased 8-fold in the
mass spectrometric analysis from supernatants of cultured my-
otubes with forced PGC-1a4 expression (Figure 2B). To further
confirm the identity of Metrnl as a bona fide secreted factor,
we expressed Metrnl in Cos7 cell line, using adenoviral vectors
expressing this protein fused to a C-terminal V5-His tag
(Metrnl-Ad) or a Lac Z (Lac Z Ad) control. Ectopic Metrnl expres-
sion produced robust increases in V5-tagged Metrnl protein in
the culture supernatants (Figure S2A). Next, we analyzed abun-
dance of Metrnl expression across various tissues. In addition to
its abundance in the skeletal muscle, it is also expressed at com-Cell 157, 1279–12parable levels in the subQ and epi WAT
depots and heart, followed by BAT and
kidney (Figure 2C).
Given that PGC-1a4 mRNA is ex-
pressed in the skeletal muscle of mice
and humans upon resistance training
(Ruas et al., 2012), we investigated the
regulation of Metrnl in human skeletal
muscle following an acute bout of con-
current exercise (resistance followed by
endurance exercise; concurrent training,
see Experimental Procedures). Skeletal
muscle biopsies from the vastus lateralis
were obtained at rest, 1 hr, and 4 hr
following the completion of the exercise
session. Figure 2D shows an increase
in Metrnl mRNA expression at both the
time-points, with maximal induction at
1 hr postexercise. In addition, we also
noted increases in PGC-1a4 (both time
points) and PGC-1a1 (1 hr only) mRNAexpression (Figure S2B). Next, we investigated the regulation
of Metrnl in a mouse model of eccentric exercise that promotes
muscle strength and hypertrophy. A single bout of downhill
treadmill running exercise increases Metrnl mRNA expression
in triceps, but not in the quadricepsmuscle (Figure 2E). Concom-
itantly, we also observe an 2-fold increase in circulating Metrnl
at day 1 postexercise, as assessed by ELISA (Figure 2E). The
specificity of the antibody against Metrnl was demonstrated
by antigen-antibody neutralization experiments using ELISA
(Figure S2C). In addition, late in the manuscript review process,
we obtained access to total body knockout (KO) mice for Metrnl;
the specificity of the antibody used here was shown definitively
with these animals (Figure S2D). We did not observe any
changes in Metrnl expression upon a program of endurance
exercise training (free wheel running) (data not shown).
Because Metrnl is regulated by exercise, we also explored
other physiological stimuli that might regulate its expression.91, June 5, 2014 ª2014 Elsevier Inc. 1281
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Metrnl  Figure 2. Identification of Metrnl as a
PGC1a4 Target Gene
(A) qPCR analysis against Metrnl in quadriceps
from Myo-PGC1a4 transgenic mice or WT litter-
mate controls (n = 4 each group).
(B) Expression of Metrnl in culture supernatants
from primary myotubes transduced with Lac Z
or PGC1a4 expressing adenovirus using mass
spectrometry (n = 3 each group).
(C) Tissue-specific Metrnl expression patterns by
qPCR. Bar graphs represent RNA samples from
three independent mice pooled together.
(D) Analysis of Metrnl gene expression in skeletal
muscle biopsies from human volunteers. Vastus
lateralis biopsies were obtained prior to
commencement and 1 hr and 4 hr postexercise.
Gene expression was analyzed by qPCR.
(E) Metrnl mRNA expression in skeletal muscle
and plasma levels after an acute bout of downhill
running exercise. C57/BL6 mice were divided into
groups: sedentary (n = 9) and run (n = 10). The
quadriceps and triceps muscles were harvested
6 hr after run and processed for gene expression
by qPCR. Plasma was collected 24 hr after the
run, and Metrnl levels were measured by ELISA.
(F) Analysis of Metrnl mRNA expression in subQ,
epi, and brown adipose tissue of mice chronically
housed at 30C or acutely subjected to a 4C cold
challenge for the indicated time points (n = 5 per
group).
(G and H) Under the same experimental setting
as in (F), plasma from mice housed at 30C or
exposed to 4C for 24 hr were subjected to (G)
western blot against Metrnl, and Metrnl band is
normalized to an invariant nonspecific band and
(H) ELISA against Metrnl. *p < 0.05, **p < 0.001,
and ***p < 0.0001.
All data are presented as mean ± SEM. See also
Figure S2 and Tables S1, S2, and S3.Given the abundance of Metrnl mRNA in the adipose tissues
(Figure 2C), we investigated its regulation by thermogenic stim-
uli, specifically acute and chronic exposure to cold. Metrnl
expression was measured in BAT, subQ, and epi fat depots of
mice chronically housed at 30C (thermoneutrality) or after an
acute (6 hr, 24 hr) and chronic challenge (2 weeks) at 4C. Acute
cold exposure significantly elevated Metrnl gene expression
in all three adipose tissues although with different kinetics of
expression (Figure 2F). Notably, Metrnl mRNA was increased
in a transient manner, with maximal induction observed at 6 hr
postchallenge. In addition, chronic cold exposure failed to
maintain elevated Metrnl expression in all three adipose tissues
examined (Figure S2E). Importantly, cold exposure for 24 hr
increased circulating levels of Metrnl, as assessed by western
blotting and ELISA assay (Figures 2G and 2H). It is interesting
to note that acute cold exposure does not induce Metrnl expres-
sion in the skeletal muscle (Figure S2F), and downhill running
exercise specifically induces Metrnl expression in the skeletal
muscle, but not in the adipose tissue (Figure S2G). Overall, these
results identify Metrnl as a hormone that can be selectively1282 Cell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc.induced in different tissues, depending upon the physiologic
stimulus. These data further suggest a potential role for this pro-
tein in the physiological adaptations to exercise and cold.
Metrnl Promotes Thermogenic and Anti-inflammatory
Gene Programs in Adipose Tissues In Vivo
To determine whether Metrnl can promote browning of adipose
tissues, we performed intravenous injections of adenoviral
vectors to deliver full-length Metrnl constructs to the liver. This
method generally results in robust expression of proteins in the
liver and potential secretion to the plasma (Wei et al., 2008).
Notably, serum aspartate aminotransferase (AST) levels were
well within the normal range and showed no differences between
the control and Metrnl-injected mice (Figure S3A). At day 3 post-
injection, we observed an 20-fold increase in liver Metrnl
mRNA (Figure S3B) and a 5- to 6-fold increase in plasma Metrnl
levels, as detected by western blotting with an anti-Metrnl anti-
body (Figure 3A). Strikingly, the increase in circulating Metrnl
produced remarkable increases in broad brown/beige fat ther-
mogenic and mitochondrial gene program in the subQ and epi
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Figure 3. Increase in CirculatingMetrnl Pro-
motes Increase in Thermogenic and Anti-in-
flammatory Gene Programs in the Adipose
Tissue
(A–H) C57/BL6 mice were injected (i.v.) with
adenoviral vectors (Ad) expressing Lac Z or Metrnl
(n = 6), and (A) plasma from these mice were
subjected to western blotting against Metrnl at day
5 postinjection.
(B and C) At day 7 postinjection, qPCR analysis
of markers associated with thermogenesis and
mitochondrial gene programs in subQ (B) and
epi WAT (C). Western blotting against UCP-1 (D)
(n = 3) and immunohistochemistry against UCP-1
in subQ WAT (E) at day 7 (n = 2).
(F) Determination of percent fat mass between
Lac Z and Metrnl-injected mice using MRI at day 7
(n = 6).
(G and H) qPCR analysis of markers associated
with b-oxidation and pro/anti-inflammatory gene
programs in the subQ WAT at day 7 (n = 6).
(I and J) C57/BL6 mice fed a HFD for 20 weeks
(n = 8) were injected daily with saline or Metrnl-Fc
protein (10mg/kg) intraperitoneally (i.p.) for 7 days,
and (I) 6 hr after the last injection, animals
were sacrificed and subQ WAT was analyzed for
changes in thermogenic, b-oxidation, and pro/
anti-inflammatory gene programs. (J) Body
weights of mice. *p < 0.05, **p < 0.001, and
***p < 0.0001.
All data are presented as mean ± SEM. See also
Figure S3.WAT, including UCP-1, DIO2, PGC-1a, and ERR-a (Figures 3B
and 3C). The increase in UCP-1 mRNA (3.5-fold) was also
accompanied by a robust increase in the UCP-1 protein expres-
sion in the subQ WAT (Figures 3D and 3E). In addition, we also
observe moderate increases in thermogenic gene programs in
the BAT (Figure S3C). Notably, changes in thermogenic gene
expression were observed only between days 5 and 7 postinjec-
tion, and the expression of UCP-1 mRNA returns to baseline
expression by day 10 (Figure S3D), even though we detect in-
creases in plasma Metrnl levels as early as day 3. Interestingly,
we observe an overall lean phenotype in Metrnl injected mice,
as evidenced by a 25% reduction in whole-body fat content
when assessed by MRI (Figure 3F). Metrnl expression also stim-
ulated elevated mRNA levels for genes associated with b-oxida-
tion such as Acsl1, Acox1, and Cpt1 (Figure 3G). Finally, the
increases in expression of thermogenic and b-oxidation geneCell 157, 1279–12programs due to Metrnl expression
were also observed in a different strain
of mice, the Balb/c strain (Figure S3E).
Increases in brown and beige fat
thermogenesis are typically inversely
correlated with changes in the expres-
sion of inflammatory genes (Chiang
et al., 2009); we therefore analyzed
whether Metrnl also regulated expression
of inflammation-linked genes. As shown
in Figure 3H, Metrnl expression promotesincreases in expression of anti-inflammatory genes such as IL-
10 and TGF-b. We did not detect any changes in expression of
proinflammatory genes such as TNF-a and IL-1b. Because
mice rendered obese by HFD display higher basal expression
of proinflammatory gene markers in adipose tissues (Hotamisli-
gil, 2006; Hotamisligil et al., 1993), we next analyzed whether
Metrnl can act to suppress expression of proinflammatory genes
in these mice. Indeed, expression of Metrnl promotes modest
decreases in expression of proinflammatory cytokines, such as
TNF-a, IFN-g, and IL-1b (Figure S3F).
To further study the ability of Metrnl to positively regulate
browning and thermogenesis, we generated and purified a re-
combinant protein fused to the Fc portion of IgG to the C termi-
nus of Metrnl (Metrnl-Fc); this was then injected into mice
rendered obese by feeding a HFD. This Metrnl protein had a rela-
tively short half-life (Figure S3G), so we injected mice daily with a91, June 5, 2014 ª2014 Elsevier Inc. 1283
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Figure 4. Metrnl Expression Increases
Energy Expenditure and Improves Glucose
Tolerance
(A–E) HFD-fed C57/BL6 mice were injected with
Lac Z or Metrnl adenovirus (i.v.) (n=7), and energy
expenditure—(A) oxygen consumption and (B)
Carbon dioxide production—was measured. (C)
Quantification of oxygen consumption between
day 5 and 6 and (D) respiratory exchange ratio
(RER). (E) Under the same experimental setting
as in (A), IP-glucose tolerance test was performed
at day 6 (n = 8). *p < 0.05, **p < 0.001, and ***p <
0.0001.
All data are presented as mean ± SEM. See also
Figure S4.dose of 10 mg/kg for 7 days. Consistent with the adenoviral
experiments, recombinant Metrnl protein increased adipose
expression of thermogenic, b-oxidation, and anti-inflammatory
genes, including UCP-1, DIO2, Acox1, and IL-10 (Figure 3I).
The magnitude of these changes was weaker than those
observed with the viral-mediated expression, presumably re-
flecting the suboptimal pharmacokinetics seen with this Metrnl
fusion protein. Nevertheless, these increases in thermogenic
gene expression were accompanied by a small but significant
reduction in body weight, compared to controls (Figure 3J).
Overall, these results identify Metrnl as a hormone that can pro-
mote an increase in a broad beige/brown fat thermogenic gene
program in vivo.
Metrnl Increases Whole-Body Energy Expenditure and
Improves Glucose Tolerance
Increase in adipose tissue thermogenesis or browning of white
fat can be accompanied by increases in whole-body energy
expenditure and improved glucose homeostasis in vivo (Bos-1284 Cell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc.tro¨m et al., 2012; Cederberg et al.,
2001). We therefore studied these meta-
bolic parameters after delivering Metrnl-
expressing adenoviral vectors to mice.
Viral vectors were used for these experi-
ments because they require less frequent
handling of the mice than protein injec-
tions. We first measured energy expendi-
ture using a comprehensive laboratory
animal monitoring system (CLAMS) and
observed a highly significant increase
in energy expenditure in Metrnl-injected
mice compared to Lac Z controls (Figures
4A–4C). Notably, the increase in oxygen
consumption and carbon dioxide produc-
tion was observed 5 days postinjection,
which is consistent with the time course
of thermogenic gene expression. This
suggests that the action of Metrnl may
not directly regulate thermogenesis but
might regulate various biological pro-
cesses that promote remodeling of the
adipose tissue in a way conducive forincreased browning of the white fat. Importantly, there was no
change in respiratory exchange ratio (RER), indicating that
Metrnl did not stimulate any substantial shift from carbohydrate
to fat-based fuels (Figure 4D). Importantly, these changes in en-
ergy expenditure were independent of food intake or locomotor
activity (Figures S4A and S4B).
Next, intraperitoneal glucose tolerance tests (GTT) were per-
formed in obese mice; Metrnl expression significantly improved
glucose tolerance when compared to control mice injected with
Lac Z (Figure 4E). Collectively, these data illustrate that increases
in circulatingMetrnl cause an increase in energy expenditure and
an improvement in glucose homeostasis in obese/diabetic mice.
Metrnl Induces IL-4/IL-13 Cytokine Expression and
Promotes AlternativeMacrophage Activation in Adipose
Tissue In Vivo
The mechanisms underpinning these effects of Metrnl were
first studied by applying recombinant Metrnl-Fc protein directly
to the stromal vascular fraction (SVF) of subcutaneous white
adipocytes during differentiation in vitro. Interestingly, there was
no detectable effect on the regulation of thermogenic or b-oxida-
tion genes such as UCP-1, DIO2, and Acsl1, etc., at varying
doses and duration of treatments tested. (Figure 5A and data
not shown). We used Fgf21 as a positive control, as it has
been previously demonstrated to induce expression of thermo-
genic genes such as UCP-1 and Cidea, in adipose cultures
(Fisher et al., 2012). Notably, the inability of Metrnl to induce
changes in gene expression was not due to inactivity of the
Metrnl-Fc protein, in that the same preparations of protein
caused adipose tissue browning in vivo (Figure 3I) and were
able to induce STAT3 phosphorylation in a dose-dependent
manner in cultured primary cortical neuron cells (Figure S5A).
In addition, we tested a commercially available recombinant
Metrnl protein and adenoviral-mediated transduction of these
same SVF cultures and got similar negative results (Figure S5B).
These results suggest that Metrnl may induce adipose tissue
thermogenesis in vivo independent of a simple, direct action
on adipocytes.
We therefore considered the possibility that this increase in
adipose tissue thermogenesis caused by Metrnl in vivo could
require actions on nonadipose cell types. To explore this further,
we first investigated whether Metrnl can induce a thermogenic
phenotype when expressed locally in adipose tissues in vivo.
Adenoviral injections were performed directly into the subQ fat
pad using Metrnl or control Lac Z adenovirus and analyzed for
changes in gene expression 5 days postinjection. This method
results in robust and localized Metrnl expression (mRNA and
protein) only at the site of injection as compared to the uninjected
contralateral side on the same mouse (Figures 5B and 5C). In
addition, we did not detect any increase in Metrnl expression
in the liver upon fat pad injections (data not shown). Importantly,
this forced expression of Metrnl produces significant increases
in both thermogenic and b-oxidation genes when compared to
mice injected with Lac Z control (Figure 5D). These results
demonstrate that, when expressed at the adipose tissue level,
Metrnl can act to induce expression of thermogenic and b-oxida-
tion genes, despite its inability to do so in primary adipocyte
cultures in vitro.
While the characteristic cell type of adipose tissue is the
adipocyte, this tissue consists of a heterogeneous population
of multiple different cell types such as preadipocytes and
many immune cells, including macrophages, eosinophils,
T cells, B cells, and mast cells. In addition to changes in the
expression of thermogenic and b-oxidation genes, we also
observed an increase in anti-inflammatory genes (e.g., IL-10) in
the adipose tissue (Figure 3H). A major source of IL-10 in the ad-
ipose tissue is known to be alternatively activated macrophages
(M2) that protect adipocytes from inflammation and improve
glucose homeostasis (Odegaard and Chawla, 2011). To investi-
gate whether Metrnl induces a phenotypic switch in adipose
tissue macrophages, we examined mRNA from the subQ WAT
of Metrnl-treated animals (adenoviral-mediated expression)
and observed significant increases in several genes associated
with alternative macrophage activation, including Arg1, Mrc-1,
Clec10a, and Retnla (Figure 5E). Notably, these changes in
gene expression associated with alternative macrophage are
robust with 5- to 6-fold increase in mRNA for Arg1 and Retnlaand3- to 4-fold increase inMrc-1 and Clec10a. These changes
were also observed in epi WAT and BAT, albeit with different
magnitude of gene expression changes (Figure S5C). In addition
to the switch in phenotype, Metrnl caused a significant increase
in the number of CD11b+ F4/80+macrophages (2.2-fold) in the
subQ WAT, as assessed by flow cytometry (Figure S5D) In
contrast, gene expression for markers of classical (M1) macro-
phage activation such as TNF-a, Nos2, and CD274 was un-
changed (Figure S5E). More importantly, Metrnl expression
also increased expression of cytokines IL-4 and IL-13 in the
adipose tissue; these are the cytokines that are dominant
regulators of the macrophage alternative activation program
(Figure 5F). The changes in IL4/IL13 gene expression were
consistently observed at early time points (days 4 to 5) after
Metrnl expression and had returned to baseline at day 7 when
we observe the increases in expression of thermogenic and
alternative macrophage activation genes. We also observed in-
creases in expression of genes associated with alternative
macrophage activation and cytokines IL4/IL13 in the adipose tis-
sue upon infusion of the recombinant Metrnl-Fc fusion protein
in vivo and with localized Metrnl expression in the fat pad using
adenoviral vectors (Figures 5G, S5F, and S5G). Notably, these
increases in IL4/IL13 gene expression and alternative macro-
phage activation in vivo were not observed with Irisin, a secreted
form of Fndc5 that has been previously shown to stimulate
adipose tissue thermogenesis via a direct action on adipocytes
(Figure 5H) (Bostro¨m et al., 2012).
Catecholamine production by alternatively activated macro-
phages has been shown to be important for induction of thermo-
genic and b-oxidation genes in WAT and BAT of cold exposed
mice (Nguyen et al., 2011). Because Metrnl promotes alternative
activation of adipose tissue macrophages, we tested whether it
promotes an increase in catecholamine production in the adi-
pose tissue. An experimental increase in circulating Metrnl
causes a significant increase in adipose expression of tyrosine
hydroxylase (Th), the rate-limiting step in the synthesis of cate-
cholamines (Figure 5I). Consistent with this, Metrnl expression
also increased the levels of norepinephrine content in the adi-
pose tissue by 2.5-fold when compared with the Lac Z control
(Figure 5J). Together, these results strongly suggest that Metrnl
induces a phenotypic switch in adipose tissue macrophages
in vivo, along with production of prothermogenic catechol-
amines, possibly via inducing expression of the M2-regulatory
cytokines IL-4 and IL-13.
Disruption of IL4/IL13 Signaling Abrogates the
Browning Response Induced by Metrnl
To investigate the requirement of IL4/IL13 signaling and alterna-
tive macrophage activation in the Metrnl-induced browning
response, we utilized two independent approaches. STAT6 is a
key transcription factor downstream of IL4/IL13 signaling, so
we first elevated Metrnl expression in STAT6 KO mice. Disrup-
tion of IL4/IL-13 signaling through the use of STAT6/ mice
(Martinez et al., 2009) completely abrogated the Metrnl-induced
increase in alternative activation of subQ WAT macrophages
(Figure 6A). This was a specific defect in M2 activation, as
STAT6 deficiency did not cause a preferential increase in clas-
sical activation markers (Figure S6A). Most importantly, STAT6Cell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc. 1285
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Figure 5. Metrnl Expression Induces an Increase in Alternative Activation of Adipose Tissue Macrophages
(A) SVF from the inguinal fat depot was differentiated into adipocytes for 6 days and treated with saline, recombinant Metrnl-Fc (5 mg/ml), or Fgf21 (100 ng/ml)
during the last 2 days of differentiation. qPCR analysis was performed for indicated genes 48 hr posttreatment (n = 4).
(B–D) SubQWAT (left pad) of C57/BL6mice was injected with either Lac Z andMetrnl adenovirus (n = 5), and the injected and contralateral WAT (right, uninjected)
were harvested (B and C) at day 3 postinjection to analyze for increase in Metrnl expression (B) by qPCR (C) western blotting and (D) at day 5 postinjection to
assess for changes in thermogenic and b-oxidation genes by qPCR.
(E and F) C57/BL6 mice were injected with adenoviral vectors expressing Lac Z or Metrnl (i.v.) (n = 6) and (E) analyzed for markers associated with alternative
macrophage activation in the subQ WAT at day 7 and (F) IL4/IL13 cytokine expression at day 5.
(G) C57/BL6 mice fed a HFD for 20 weeks (n = 8) were injected daily with saline or Metrnl-Fc protein (10 mg/kg) (i.p.) for 7 days and analyzed for changes in
markers of M2 macrophage activation in the subQ WAT.
(H–J) (H) BALB/cmicewere injectedwith Lac Z or Fndc5-Ad (i.v.). Animals were sacrificed 7 days later, and subQWATwas assessed for indicated genes by qPCR
(I and J) under the same experimental setting as in (E and F), (I) tyrosine hydroxylase mRNA expression, and (J) norepinephrine content of subQ adipose tissue at
day 7. *p < 0.05, **p < 0.001, ***p < 0.0001, and ****p < 0.00001.
All data are presented as mean ± SEM. See also Figure S5.
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deficiency significantly attenuated the expression of the broad
range of beige fat thermogenic genes (UCP-1 and PGC-1a)
and the b-oxidation genes (Acsl1 and Acox1) in the STAT6
KOs, compared to the wild-type mice (Figure 6B). Next, in an in-
dependent approach, we abrogated IL4/IL13 signaling using a
neutralizing antibody against the IL-4 receptor a chain (IL4Ra).
This receptor subunit is utilized by both IL-4 and IL-13 to pro-
mote alternative activation in macrophages (Martinez et al.,
2009). Consistent with the results obtained with the genetic
STAT6 deficiency, blockade of IL-4Ra completely abrogated
the Metrnl-induced increase in genes characteristic of alterna-
tive macrophage activation and blunted the expression of the
beige fat thermogenic and b-oxidation gene programs (Figures
S6B and S6C).
Next, we investigated whether the increase in catecholamines
driven by Metrnl is dependent on IL4/IL13 signaling and/or in-
crease in alternative macrophage activation. Metrnl expression
caused significant increases in mRNA expression for tyrosine
hydroxylase and stimulated catecholamine secretion from
adipose tissues derived from WT mice (Figures 6C and 6D).
However, loss of IL4/IL13 signaling in STAT6/mice abrogated
Metrnl-induced increase Th and reduced norepinephrine con-
tent in the subQ WAT by 60%–70% in STAT6/ mice,
compared to those seen in the WT mice (Figures 6C and 6D).
Consistent with the results obtained with STAT6/ mice,
blockade of IL-4Ra significantly reduced norepinephrine content
in the subQ WAT (Figure S6D). These observations demonstrate
that induction of IL4/IL13 expression and alternative macro-
phage activation by Metrnl is essential to promote production
of catecholamines and to regulate of expression of genes asso-
ciatedwith brown/beige adipose thermogenesis and b-oxidation
gene programs.
Metrnl Stimulates an Eosinophil-Dependent Increase in
IL4/IL13 Expression and Alternative Macrophage
Activation in the Adipose Tissue
These observations strongly suggest that the ability of Metrnl to
induce IL4/IL13 expression is key to the cascade of events lead-
ing to increases in expression of UCP-1 and other thermogenic
genes in fat. Interestingly, primary bone-marrow-derived macro-
phages did not induce IL4/IL13 and were unable to undergo
alternative activation when treated with recombinant Metrnl-Fc
protein in vitro (Figure S6E).
How does Metrnl increase expression of IL4/IL13 in the
adipose tissue? It has been previously demonstrated that eosin-
ophils are the major IL-4-producing cells within white adipose
tissue (Wu et al., 2011), and their presence is required for
the maintenance of alternatively activated macrophages. Using
sialic-acid-binding immunoglobulin receptor (Siglec-F) and
Ccr3 as molecular markers for eosinophils, we next investigated
whether circulating Metrnl causes an increase in the number or
trafficking of eosinophils into the adipose tissues (the eosinophil
gating strategy is shown in Figure S6F). Systemic Metrnl expres-
sion through the use of adenoviral vectors caused a significant
increase in adipose mRNA levels of both Siglec-F and Ccr3
(6.5-fold) (Figure S6G) and in the number of eosinophils in the
subQ WAT by 2.7-fold, as assessed by flow cytometry (Fig-
ure 6E). The kinetics of expression of Siglec-F mRNA was com-parable to those of IL-4 in the subQ WAT (Figure S6J). Notably,
Siglec-F and IL-4 expression is induced by day 3, peaks at day
4, and returns to baseline expression by day 7 (Figure S6J).
The increased expression of these molecular eosinophil markers
was also observed with recombinant Metrnl-Fc protein (Fig-
ure S6H) and with localized Metrnl expression in the fat pad
using adenoviral vectors (Figure S6I). However, Metrnl did not
cause an increase in other IL-4-expressing cells types, such as
T cells and basophils (Figures S6K and S6L), whereas mast cells
were not detected in the SVF from subQWAT. These results indi-
cate that systemic administration of Metrnl causes increases in
adipose tissue eosinophils and strongly suggests that this eosin-
ophil recruitment is a likely source of much of the IL-4 induced by
Metrnl in the adipose tissue.
To determine whether eosinophils are the primary source of
IL4/IL13 upon Metrnl treatment, we used mice with a Gata1 pro-
moter mutation that lacks eosinophils (DdblGATA mice) (Yu
et al., 2002). The absence of eosinophils completely abrogated
the Metrnl-induced increase in IL4/IL13 expression in the subQ
WAT at day 4 postinjection (Figure 6F). Notably, and consistent
with our observation with disruption of IL4/IL13 signaling, Metrnl
was not able to induce expression of genes associated with
alternativemacrophage activation inDdblGATAmice (Figure 6G).
Finally, the induction of thermogenic genes (UCP-1, Dio2, and
PGC-1a1) induced by Metrnl was significantly blunted (50%–
60%) in the DdblGATA mice at day 7 (Figure 6G). These results
demonstrate that eosinophils are the primary source of Metrnl-
induced IL4/IL13 in the adipose tissue, and they are required
for increased alternative macrophage activation and induction
of thermogenic gene responses.
Metrnl Is Required for Cold-Induced Adaptive
Thermogenesis
Metrnl expression is induced upon cold challenge in the adipose
tissue, resulting in increases in circulating Metrnl levels (Figures
2F–2H). Given that Metrnl induces eosinophil-dependent IL4/
IL13 expression in the adipose tissue, we investigated whether
cold challenge also promotes an increase in eosinophil numbers
and IL4/IL13 expression. Acute exposure (24 hr) of mice to cold,
after being chronically housed at thermo-neutral temperatures,
promotes a significant increase (3-fold) in the number of eosin-
ophils and a concomitant increase in IL4/IL13 expression in the
subQ WAT (Figures 7A and 7B). The increase in adipose tissue
eosinophils, combined with the previously established role of
IL4/IL13 signaling and M2 macrophages in cold-induced ther-
mogenesis (Nguyen et al., 2011), suggests a potential role for
Metrnl in cold-induced increases in IL4/IL13 expression. This,
in turn, could lead to M2 macrophage activation and induction
of thermogenic genes.
To directly examine the role of Metrnl in cold adaptation, mice
housed at thermoneutrality were injected with anti-Metrnl anti-
body to neutralize Metrnl in vivo and then exposed to cold 6 hr
later. As shown in Figure 7C, the anti-Metrnl antibody dramati-
cally reduced the mRNA expression of Siglec F and IL4/IL13
and the number of eosinophils induced upon cold challenge
(acute, 24 hr) when compared to an isotype or control antibody.
We next investigated the role of endogenous Metrnl in
regulating expression of thermogenic genes. With 72 hr ofCell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc. 1287
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Figure 6. Metrnl-Induced Browning Response Requires IL4/IL13 Signaling
(A and B) WT and STAT6/ mice (n = 5) were injected with Lac Z or Metrnl-Ad (i.v.) and analyzed at day 7 postinjection for markers associated with (A) M2
macrophage activation and (B) thermogenic and b-oxidation genes.
(C and D) Under the same experimental setting as in (A) and (B), (C) tyrosine hydroxylase mRNA expression and (D) norepinephrine content of subQ WAT were
assessed at day 7.
(E) C57/BL6 mice were injected with Lac Z or Metrnl-Ad (i.v.) (n = 4) and flow cytometric analysis of eosinophils (defined as CD11b+ and Siglec F+; gating strategy
in Figure S6F) in the SVF from subQ WAT at day 4. Numbers represent percentage of CD11b+/Siglec F+ cells in total SVF.
(legend continued on next page)
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Figure 7. Metrnl Is Required for Physiologic
Adaptation to Cold Temperatures
(A and B) Mice chronically housed at 30C were
subjected to a 4C cold challenge for 24 hr, and
the (A) number of adipose eosinophils (gated as
described in Figure S7F) is shown per g adipose
tissue. (B) mRNA expression of IL4/IL13 in the
subQ WAT.
(C and D) Mice chronically housed at 30C were
injected with isotype or Metrnl antibody (i.p.) and
moved to cold 6 hr later. SubQWATwas harvested
and analyzed for (C) mRNA expression of the
indicated genes and number of eosinophils per g
adipose tissue at 24 hr post-cold-challenge; (D)
markers of genes associated with thermogenic
and M2macrophage activation at 72 hr post-cold-
challenge. **p < 0.001 and ***p < 0.0001 compar-
ison between mice at 30C and 4C or isotype Ab
treatment of mice at 30C and 4C. #p < 0.05 and
##p < 0.001 comparison between Metrnl Ab treat-
ment of mice at 30C and 4C.
All data are presented as mean ± SEM. See also
Figure S7.cold challenge, antibody neutralization of Metrnl significantly
inhibited the expression of genes characteristic of M2 macro-
phages (Arg-1, Mrc-1, and Clec-10a) and adipose thermogene-
sis (UCP-1, Dio2, and PGC-1a) (Figure 7D). For example, Arg-1
mRNA levels are decreased by 70%, and UCP1 mRNA levels
are decreased by 55% (Figure 7D). Moderate but significant
attenuation of thermogenic and M2 macrophage genes was
also observed at 48 hr post-cold-challenge, as evidenced by
a 40% reduction in Arg-1 mRNA levels and 30% reduction in
UCP-1 mRNA levels (Figure S7B). However, with 24 hr of cold
exposure, the induction of thermogenic genes (UCP-1 and
PGC-1a) was not altered with anti-Metrnl treatment, although(F and G) WT and DdblGATA mice (n = 5) were injected with Lac Z or Metrnl-Ad (i.v.) and analyzed for (F)
macrophage and thermogenic genes at day 7. *p < 0.05, **p < 0.001, and ***p < 0.0001 comparison betw
#p < 0.05, ##p < 0.001, and ###p < 0.0001 comparison between STAT6/ orDdblGATAmice injected with Lac
0.0001 comparison between WT or STAT6//DdblGATA mice injected with Metrnl-Ad.
All data are presented as mean ± SEM. See also Figure S6.
Cell 157, 1279–12we do observe consistent and significant
reduction in expression of Dio2 (Fig-
ure S7A). In addition, this cold exposure
period did not induce expression of
M2 macrophage-associated genes (Fig-
ure S7A), although we do observe an in-
crease in eosinophil numbers and IL4/
IL13 expression at this time point (Fig-
ures 7A and 7B). Taken together, these
results indicate that Metrnl is required
for a substantial part of host’s adaptive
thermogenesis in response to cold chal-
lenge. Importantly, these results impli-
cate a physiological role for Metrnl in
coordinating an eosinophil-dependent
increase in IL4/IL13 expression, alterna-tive macrophage activation, and expression of thermogenic
genes upon chronic exposure to cold.
DISCUSSION
Using unbiased genetic and proteomic approaches, we report
here the identificationMetrnl, a protein that is induceduponphys-
iological stimuli such as exercise and cold exposure. This protein
is unique in several respects. First, it utilizes a rather unconven-
tional mechanism to stimulate thermogenesis by inducing im-
munecytokines (IL4/IL13)whose actions are necessary to induce
expressionof thermogenic genes. The role ofM2macrophages inIL-4/IL13 mRNA expression at day 4 and (G) M2
een WT mice injected with Lac Z and Metrnl-Ad.
Z andMetrnl-Ad. +p < 0.05, 2+p < 0.001, and +++p <
91, June 5, 2014 ª2014 Elsevier Inc. 1289
potentiating cold-induced thermogenesis was recently illus-
trated by the important work of Chawla and colleagues (Nguyen
et al., 2011). This mechanism distinguishes Metrnl from other
known polypeptide inducers of thermogenesis, such as Irisin
and Fgf-21, which both act directly on adipocytes to stimulate
thermogenesis (Bostro¨m et al., 2012; Fisher et al., 2012; Zhang
et al., 2013). Second, in addition to stimulating thermogenesis,
Metrnl also promotes a macrophage phenotype associated
with the suppression of inflammatory cytokines. Importantly,
the ability of Metrnl to recruit and engage immune cell types to
promote thermogenesis is demonstrated by three independent
approaches used in the present study: use of adenoviral vectors
to increase circulating Metrnl, use of localized Metrnl expression
by direct injection of these viruses into fat pads, and the systemic
injection of recombinant Metrnl-Fc fusion proteins.
Observation of the time course of events taking place after
Metrnl expression has allowed delineation of the cascade of pro-
cesses leading from Metrnl to increase in expression of UCP-1
and other thermogenic genes. It is clear that increases in circu-
lating Metrnl recruits eosinophils into the adipose tissue, which
are themajor source of the cytokines IL-4 and IL-13. It is possible
that Metrnl may induce expression of eosinophil-specific che-
mokines in the adipose cells, thereby giving circulating Metrnl
highly localized actions. Abrogation of IL4/IL13 signaling abol-
ishes the increases in alternative macrophage activation, cate-
cholamine secretion, and expression of beige fat thermogenic
genes. These studies further illustrate a highly regulated pathway
to brown/beige fat thermogenesis that is parallel to the classical
SNS pathway. Importantly, the attenuation of cold-induced ther-
mogenic response upon blocking Metrnl actions in vivo clearly
attributes a physiological role for Metrnl in long-term adaptation
to cold temperatures.
Given the ability of Metrnl to induce alternative macrophage
activation and brown/beige fat thermogenesis, its therapeutic
potential in metabolic diseases is obvious. The recombinant
Metrnl protein used here hints at that potential, but other proteins
with better pharmacological properties will be required. The
important role of eosinophils and M2 macrophages in other
repair processes, including those in damaged muscle (Arnold
et al., 2007; Heredia et al., 2013) and liver (Goh et al., 2013), sug-
gests additional interesting therapeutic applications.
EXPERIMENTAL PROCEDURES
Animals and In Vivo Experiments
All animal experiments were performed according to procedures approved by
Beth Israel Deaconess Medical Center (BIDMC) Institutional Animal Care and
Use Committee (IACUC). Wild-type C57/BL6J, STAT6/ mice (BL/6), BALB/
cJ, andDdblGATAmice on a BALB/cJ backgroundwere purchased from Jack-
son Laboratory. The Myo-PGC-1a4 transgenic mice have been previously
described (Ruas et al., 2012). Mice heterozygous for Metrnl were purchased
from Taconic and were bred in house to obtain Metrnl KO animals. Additional
information can be found in Extended Experimental Procedures.
Human and Mouse Exercise Training Program
The experimental procedures and possible risks with the study were explained
to all subjects, who gave written informed consent before participation. The
Human Research Ethics Committee of RMIT University approved the study.
Human concurrent exercise protocol was as follows: eight healthy male sub-
jects (age 19.1 ± 1.4 years, body mass 78.1 ± 15.6 kg, peak oxygen uptake1290 Cell 157, 1279–1291, June 5, 2014 ª2014 Elsevier Inc.[VO2peak] 46.7 ± 4.4 ml/kg/min, leg extension one repetition maximum
[1-RM] 130 ± 14 kg; values are mean ± SD) completed a single bout of resis-
tance exercise and cycling (concurrent exercise) after 48 hr diet and exercise
control. In brief, subjects performed eight sets of five repetitions leg extension
at 80% 1RM and then rested for 15 min before completing 30 min of contin-
uous cycling at70% of individual VO2peak. Skeletal muscle biopsies from the
vastus lateralis were obtained at rest and 1 and 4 hr postexercise. Mouse
downhill running exercise: mice were randomly placed into sedentary (n = 9)
or downhill exercise groups (n = 10). Mice ran at 20 degrees at 15 m/m for
60 min after a 5 min warm up at 10 m/m. Mice were sacrificed 6 hr after the ex-
ercise bout. For mouse endurance exercise training, mice were housed and
exercised as described previously (Chinsomboon et al., 2009).
Statistical Analysis
All data are presented as mean ± SEM and analyzed using Prism (Graphpad).
Statistical significance was determined using Student’s t test. p < 0.05 was
considered to be statistically significant and is presented as *(p,0.05),
**(p,0.01), or ***(p,0.001).SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2014.03.065.
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